ORIGINALLY described by Lugaresi et al, in 1986 (ref. 1), fatal famili
al insomnia (FFI) is a rare inherited neurological disease characteriz
ed by the subacute progression of intractable insomnia and other auton
omic abnormalities, cerebellar and pyramidal signs; myoclonus and deme
ntia; neuropathologically, the major feature is severe neuronal loss w
ith associated gliosis in the ventral and mediodorsal thalamic nuclei.
The disease has been related to the group of spongiform encephalopath
ies by virtue of the presence of low levels of proteinase-resistant am
yloid protein (PrPres) in the brain(2-4), and of a pathogenic single-a
llele mutation at codon 178 of the PRNP gene that encodes PrPres (refs
2, 5). Here rye report the successful transmission of the disease to
experimental animals, placing FFI within the group of infectious cereb
ral amyloidoses.